MediWound announced that it intends to effect a 1-for-7 reverse share split of its ordinary shares. Subject to the company’s satisfaction of Nasdaq Operations notice requirements, the scheduled effective date is December 20, with trading on a reverse split-adjusted basis to begin at market open on that day. Trading of the company’s ordinary shares will continue on the Nasdaq Global Market under the symbol (MDWD), but the shares will trade under the new CUSIP number, M68830112. In the event of a delay in the effective date, the company will update the public via a subsequent press release.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MDWD:
- MediWound Announces a 1-for-7 Reverse Share Split
- MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update
- MediWound’s EscharEx Featured in Paper as a Potential Paradigm Shift Towards Non-Surgical Wound Bed Preparation in DFUs
- MediWound Announces Formation of Strategic Advisory Board
- MediWound’s EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022